Joanna Moncrieff
@joannamoncrieff.bsky.social
660 followers 9 following 150 posts
Critical psychiatrist, professor at University College London and author. Views are my own.
Posts Media Videos Starter Packs
Pinned
joannamoncrieff.bsky.social
Good to be up on bsky. Following the storm of interest provoked by our 2022 review, I am pleased to announce the publication of my book telling the story of the serotonin theory of depression from the beginning to recent challenges. Due out Jan 2025. To pre-order lnk.to/chemicallyim...
joannamoncrieff.bsky.social
Looking forward to taking part in the HTLGI festival in Kenwood House, London, Sept 20-21st. The line up of amazing scientists, thinkers & political figures including Brain Cox, Roger Penrose, Alastair Campbell, Diane Abbott etc. Tickets howthelightgetsin.org/festivals/lo...
joannamoncrieff.bsky.social
Blog on the longstanding tendency to play down the dependence-inducing effects of psychiatric drugs, now playing out in two reviews that minimise antidepressant withdrawal effects based on flawed studies of short-term users www.psychologytoday.com/us/blog/chem...
Antidepressant Withdrawal: Nothing to Worry About?
Recent reviews claim antidepressant withdrawal is clinically insignificant, but they are based on flawed and short-term studies. Minimizing withdrawal problems is worrying.
www.psychologytoday.com
Reposted by Joanna Moncrieff
ploederl.bsky.social
When Dr. Roussos-Ross pointed out the dangers of untreated depression, she left out the fact that antidepressants (ADs) have modest efficacy (as later pointed out by @joannamoncrieff.bsky.social ). Bc of the side effects, ADs are associated with a problematic harm-benefit ratio for the majority.
joannamoncrieff.bsky.social
I was honoured to take part in the FDA's panel on the risks of SSRIs in pregnancy yesterday along with other experts @fda.gov. This is a huge issue with so many young women taking these drugs. I hope the UK and other countries will listen to the evidence presented www.youtube.com/watch?v=2Nha...
FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy
YouTube video by U.S. Food and Drug Administration
www.youtube.com
joannamoncrieff.bsky.social
It is worrying that leading psychiatrists have quoted the Henssler review regardless of these limitations (and the more recent Kalfas review) to reassure the public and called on the Royal College of Psychiatrists to weaken its advice on stopping antidepressants 4/n
joannamoncrieff.bsky.social
Only 5 studies in the Henssler AD withdrawal review (not 18 as claimed) used a relevant measure of withdrawal. These find 55% of people reported withdrawal symptoms after stopping antidepressant 3/n
joannamoncrieff.bsky.social
The vast majority of included studies in the Henssler AD withdrawal review were not designed to measure withdrawal and only recorded it incidentally among spontaneously reported ‘adverse events’. This is no basis for estimating prevalence 2/n
joannamoncrieff.bsky.social
Our rapid response in the BMJ highlights how the recent antidepressant withdrawal review confirms withdrawal effects with SSRIs and SNRIs but underestimates their significance due to relying on short-term trials and other methodological problems @ploederl.bsky.social www.bmj.com/content/390/...
Review underestimates antidepressant withdrawal effects
www.bmj.com
Reposted by Joanna Moncrieff
ploederl.bsky.social
Our rapid response to a summary of the new problematic antidepressant withdrawal study has been published, together with other interesting and important ones (e.g., by @markhoro.bsky.social ).
@joannamoncrieff.bsky.social
www.bmj.com
joannamoncrieff.bsky.social
Useful thread on this study
ploederl.bsky.social
1. The important study by Rosenbaum et al.'s used a sample of pts who were on antidepressants for 4-12 months. Pts were randomized to placebo vs. continuation for 5-8 days. They did not report the diffs for SMD and MD bc the continuation sample was very small. So I calculated the results
joannamoncrieff.bsky.social
Useful thread critiquing the recent review of antidepressant withdrawal
ploederl.bsky.social
1. This new systematic review on withdrawal problems after stopping antidepressants (AD) already caused a lot of discussion. According to aggregated studies, stopping ADs caused about 1-2 additional withdrawal symptoms compared to continuation (or before stopping or a placebo control)
However ->
Incidence and Nature of Antidepressant Discontinuation Symptoms
This systematic review and meta-analysis examines the presence and incidence of discontinuation symptoms in individuals who stop taking antidepressants.
jamanetwork.com
Reposted by Joanna Moncrieff
ploederl.bsky.social
Occurrence of a discontinuation syndrome in the 5-8 day discontinuation period, defined by Rosenbaum et al. as 4+ withdrawal symptoms: 60% sertraline, 66%paroxetine, and 14% fluoxetine (which can serve as control group).
This conforms the ca. 50% occurrence, which was dismissed by Hayes 🤔
Reposted by Joanna Moncrieff
Reposted by Joanna Moncrieff
ploederl.bsky.social
Also note that the SMD's for individual SSRI/SNRI's ranged between 0.39 and 0.68.
In the study of Rosenbaum, where patients were on antidepressants much longer (average ca. 11 months), the increase in DESS symptoms after stopping meds was 6 and 8 for sertraline and paroxetine, respectively.
Reposted by Joanna Moncrieff
ploederl.bsky.social
Besides the double standards, the main problem is that the result from the main analysis is based on short-term trials (ca 8w) except one 26w agomelatine trial. Not much withdrawal can be expected but was nonetheless observed - concerning! Most are on ADs much longer. Absurd conclusions!
joannamoncrieff.bsky.social
Thread on our response to Ghaemi and how Ghaemi's article became more hostile and pejorative after peer review
ploederl.bsky.social
Remember the harsh reactions we faced after we published a meta-analysis about lithium's suicide preventive effects?
Out rebuttal to Nassir Ghaemi, who attacked us with inappropriate language (which should never have passed peer review) is now published.
journals.sagepub.com/doi/10.1177/...
Uncertainty about lithium and suicide: A response to Nassir Ghaemi - Joanna Moncrieff, Jacki Stansfeld, Lisa Wood, Martin Plöderl, 2025
journals.sagepub.com
Reposted by Joanna Moncrieff
heartforward.bsky.social
There’s no strong evidence of a chemical imbalance behind depression, yet antidepressants are still pushed to serve pharma profits and uphold psychiatry’s medical image.

@joannamoncrieff.bsky.social's compelling interview.
www.youtube.com/watch?v=zcBu...
This Psychiatrist Says Chemical Imbalance is a LIE
YouTube video by Dr. Josef
www.youtube.com
Reposted by Joanna Moncrieff
mad-in-america.bsky.social
Liberation Psychology Gains Ground in a Fractured World

As crises of displacement and inequality intensify, more scholars are turning to Liberation Psychology’s commitment to structural change.

By Micah Ingle, PhD

www.madinamerica.com/2025/06/libe...
Liberation Psychology Gains Ground in a Fractured World
As crises of displacement and inequality intensify, more scholars are turning to Liberation Psychology’s commitment to structural change.
www.madinamerica.com
joannamoncrieff.bsky.social
I enjoyed my trip to the How The Light Gets In festival
in Hay. My talk was packed out and there were was a good discussion. The festival was a great combination of serious debate and fun